Benuvia Therapeutics Inc. finances and develops low-risk assets with high clinical value to improve the quality of life for patients with rare and underserved diseases. They have a broad pipeline of clinical stage product candidates based on nearly a decade of clinical research. Benuvia seeks partners to support the future development of these candidates through the 505(b)2 pathway. Additionally, Benuvia Manufacturing offers technology solutions for Active Pharmaceutical Ingredient (API) and drug product development. They provide drug discovery, formulation development, and testing of pharmaceutical ingredients.